Trial intelligence / Profile preview

Dexmedetomidine for Preventing Contrast Induced Nephropathy

NCT02137863Phase 4Completed

Sponsor
Erciyes University
Start
Jun 2011
Primary completion
Jun 2012
Modality
Small Molecules
01

Overview

A Phase 4 trial of dexmedetomidine in contrast-induced nephropathy (CIN), sponsored by Erciyes University. Started Jun 2011; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

contrast-induced nephropathy (CIN)

Beyond the preview

Go deeper on NCT02137863.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02137863.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call